Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 25.64
-0.20 (-0.77%)
Sep 11, 2026, 2:55 PM HKT
Giant Biogene Holding Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
| 27,434 | 28,135 | 35,467 | 61,083 | 50,360 | 46,273 | 34,746 | 33,965 | 32,794 | - | - | |
Market Cap Growth (YoY) | -58.87% | -53.94% | -29.57% | 32.01% | 44.94% | 36.24% | 5.95% | - | - | - | - |
Enterprise Value | 18,925 | 18,893 | 25,777 | 54,847 | 43,851 | 42,110 | 31,750 | 31,464 | 31,531 | - | - |
Last Close Price | 25.84 | 26.50 | 31.74 | 55.03 | 46.52 | 42.75 | 32.52 | 31.79 | 30.69 | - | - |
Price Ratios
Fiscal Quarter | Current | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
PE Ratio | 14.23 | 14.57 | 16.64 | 24.65 | 22.95 | 24.36 | 21.73 | 29.88 | 41.68 | - | - |
Forward PE | 11.49 | 12.12 | 12.61 | 20.48 | 19.66 | 22.10 | 19.71 | 22.88 | 26.93 | - | - |
PS Ratio | 4.46 | 4.58 | 5.78 | 9.12 | 8.54 | 9.66 | 8.95 | 10.53 | 12.27 | - | - |
PB Ratio | 2.54 | 2.60 | 3.21 | 6.07 | 6.65 | 7.21 | 7.22 | 8.94 | 10.23 | - | - |
P/TBV Ratio | 2.54 | 2.61 | 3.22 | 6.08 | 6.66 | 7.22 | 7.24 | 8.97 | 10.26 | - | - |
P/FCF Ratio | - | - | 23.56 | 37.82 | 26.37 | 25.75 | 22.19 | 30.94 | 37.24 | - | - |
P/OCF Ratio | - | - | 17.90 | 30.39 | 23.18 | 22.94 | 19.14 | 23.94 | 31.14 | - | - |
PEG Ratio | 1.19 | 1.29 | 1.94 | 1.12 | 0.85 | 0.85 | 0.78 | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
EV/Sales Ratio | 3.08 | 3.07 | 4.20 | 8.19 | 7.44 | 8.79 | 8.18 | 9.75 | 11.80 | - | - |
EV/EBITDA Ratio | 9.19 | 9.19 | 10.55 | 19.15 | 17.72 | 19.41 | 17.54 | 21.24 | 24.07 | - | - |
EV/EBIT Ratio | 9.60 | 9.60 | 10.92 | 19.59 | 18.06 | 19.76 | 17.88 | 21.69 | 24.61 | - | - |
EV/FCF Ratio | - | - | 17.13 | 33.96 | 22.96 | 23.43 | 20.28 | 28.66 | 35.80 | - | - |
Financial Efficiency
Fiscal Quarter | Current | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00 | 0.00 | - | - |
Debt / FCF Ratio | - | - | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
Net Debt / Equity Ratio | -0.79 | -0.79 | -0.84 | -0.96 | -0.82 | -1.01 | -0.87 | -0.79 | -0.78 | - | - |
Net Debt / EBITDA Ratio | -4.18 | -4.15 | -3.79 | -3.39 | -2.52 | -3.00 | -2.31 | -2.03 | -1.91 | - | - |
Net Debt / FCF Ratio | - | - | -6.15 | -6.01 | -3.27 | -3.62 | -2.66 | -2.73 | -2.84 | - | - |
Return on Capital Employed (ROCE) | 17.80% | 18.00% | 21.10% | 27.60% | 31.70% | 32.90% | 36.30% | 37.90% | 39.70% | - | - |
Yields
Fiscal Quarter | Current | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | May '21 May 31, 2021 |
Earnings Yield | 7.04% | 6.86% | 6.01% | 4.06% | 4.36% | 4.11% | 4.60% | 3.92% | 3.45% | - | - |
FCF Yield | - | - | 4.24% | 2.64% | 3.79% | 3.88% | 4.51% | 3.23% | 2.69% | - | - |
Buyback Yield / Dilution | -4.18% | -0.60% | -7.98% | -3.58% | -3.20% | -0.72% | 2.76% | 4.71% | 1.30% | - | - |